Sonic Healthcare demonstrated strong financial performance and strategic growth through acquisitions and new contracts. However, challenges in the U.S. market and regulatory pressures pose some risks. The company's outlook remains positive, with expected strong earnings growth in FY 2026.

Company Guidance

During the Sonic Healthcare conference call for the fiscal year ended June 30, 2025, the company reported positive financial metrics and provided guidance for the upcoming year. Revenue for FY 2025 was $9.645 billion, marking an 8% increase from the prior year, while EBITDA also rose 8% to $1.725 billion. Net profit reached $514 million, up 7%, with cash generation nearing $1.3 billion and earnings per share of $0.1067. The company achieved its guidance with a constant currency EBITDA of $1.702 billion, and organic revenue growth was 5%. Looking ahead to FY 2026, Sonic Healthcare expects strong earnings growth, driven by organic growth and synergies from acquisitions in Switzerland and Germany, particularly from LADR. The EBITDA guidance for FY 2026 is set between $1.87 billion and $1.95 billion on a constant currency basis, equating to $1.94 billion to $2.02 billion using current exchange rates, reflecting up to 13% EBITDA growth from FY 2025, or about 16% growth with current exchange rates. The company anticipates an effective tax rate of around 27% and an interest expense increase of 15% to 20% on a constant currency basis. Sonic Healthcare also announced a final dividend of $0.63 per share, with total dividends for the year up 1% to $1.07 per share.

Strong Financial Performance

Sonic Healthcare reported revenue of $9.645 billion, up 8% from the previous year. EBITDA also increased by 8%, reaching $1.725 billion, and net profit rose by 7% to $514 million.

Successful Acquisitions and Integration

The company successfully integrated several acquisitions, including LADR in Germany, which will contribute significant revenue. Synergies from Swiss acquisitions are expected to peak in FY 2026 and FY 2027.

Positive Outlook for FY 2026

Guidance for FY 2026 suggests strong earnings growth, with expected EBITDA of $1.87 billion to $1.95 billion on a constant currency basis, representing up to 13% growth on FY 2025.

Expansion in Australian Pathology

Australian Pathology division showed strong performance with organic revenue growth of 6% and successful cost management strategies.

New Contracts and Market Expansion

Sonic Healthcare won new contracts in the U.K. and Australia, including lab services for North Shore Private Hospital and Hollywood Private Hospital. They also secured a contract for the National Bowel Cancer Screening program.

Sonic Healthcare (SKHHY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

SKHHY Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Feb 23, 2026	2026 (Q2)	0.37 / -	0.315	―	―	―
Aug 20, 2025	2025 (Q4)	0.39 / 0.37	0.401	-7.73% (-0.03)
Feb 19, 2025	2025 (Q2)	0.32 / 0.32	0.28	12.50% (+0.03)
Aug 21, 2024	2024 (Q4)	0.40 / 0.40	0.436	-8.03% (-0.03)
Feb 19, 2024	2024 (Q2)	0.42 / 0.28	0.556	-49.64% (-0.28)
Aug 17, 2023	2023 (Q4)	0.49 / 0.44	0.913	-52.25% (-0.48)
Feb 15, 2023	2023 (Q2)	0.57 / 0.56	1.232	-54.87% (-0.68)
Aug 23, 2022	2022 (Q4)	0.78 / 0.91	0.964	-5.29% (-0.05)	―	―
Feb 20, 2022	2022 (Q2)	1.30 / 1.23	1.101	11.90% (+0.13)	―	―
Aug 22, 2021	2021 (Q4)	1.02 / 0.96	0.394	144.67% (+0.57)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

SKHHY Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 20, 2025	$18.03	$15.70	-12.92%
Feb 19, 2025	$17.61	$17.25	-2.04%
Aug 21, 2024	$17.58	$17.66	+0.46%
Aug 17, 2023	$18.77	$19.06	+1.55%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sonic Healthcare Limited (SKHHY) report earnings?

Sonic Healthcare Limited (SKHHY) is schdueled to report earning on Feb 23, 2026, TBA (Confirmed).

What is Sonic Healthcare Limited (SKHHY) earnings time?

Sonic Healthcare Limited (SKHHY) earnings time is at Feb 23, 2026, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is SKHHY EPS forecast?

SKHHY EPS forecast for the fiscal quarter 2026 (Q2) is 0.37.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing